Consistently, in the pulmonary embolism model, QLQX reduced the number of pulmonary vascular thrombi (Fig. 5B) and decreased platelet accumulation in the lung, as indicated by smaller CD42b+ area (Fig. 5C). Here, GP1BA is linked to pulmonary embolism.